Health Condition 1: - Health Condition 2: L509- Urticaria, unspecified
Conditions
Interventions
Intervention1: Group 1 patients receiving only tab levocetirizine: 31 patients will receive Tab levocetirizine 5 mg once daily initially with subsequent increment as per patient requirement upto maxim
Sponsors
Dr Disha Chakraborty
Dr Abhishek De
Eligibility
Inclusion criteria
Inclusion criteria: Patient of chronic spontaneous urticaria presenting in the outpatient department of Dermatology.
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. There can be altered levels of serum vitamin D in the patients of CSU when compared to age-matched healthy control at baseline. 2. There can be correlations of serum vitamin D levels with disease severity & duration at baseline, 4 weeks, 8 weeks. 3. There can be a difference in disease control (UAS7 score and) tablet score between the two groups at baseline, 4 weeks and the end of 8 weeks. Timepoint: 1. There can be altered levels of serum vitamin D in the patients of CSU when compared to age-matched healthy control at baseline. 2. There can be correlations of serum vitamin D levels with disease severity & duration at baseline, 4 weeks, 8 weeks. 3. There can be a difference in disease control (UAS7 score and) tablet score between the two groups at baseline, 4 weeks and the end of 8 weeks. | — |
Secondary
| Measure | Time frame |
|---|---|
| Is there any correlations of serum vitamin D levels with disease severity & duration. Is there can be a difference in disease control (UAS7 score and) tablet score between the two groups at the end of 8 weeks? Timepoint: 8 weeks | — |
Countries
India
Contacts
Public ContactDisha Chakraborty
Calcutta National Medical College and Hospital
Outcome results
None listed